Fennec Pharmaceuticals In...

NASDAQ: FENC · Real-Time Price · USD
8.50
-0.03 (-0.35%)
At close: Aug 15, 2025, 10:20 AM
-0.35%
Bid 8.5
Market Cap 234.84M
Revenue (ttm) 30.91M
Net Income (ttm) -14.44M
EPS (ttm) -0.53
PE Ratio (ttm) -16.04
Forward PE 9.39
Analyst Strong Buy
Ask 8.68
Volume 12,861
Avg. Volume (20D) 82,198
Open 8.62
Previous Close 8.53
Day's Range 8.48 - 8.65
52-Week Range 3.96 - 9.42
Beta 0.40

About FENC

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FENC
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for FENC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Fennec Pharmaceuticals has released their quartely earnings on Aug 14, 2025:
  • Revenue of $9.65M exceeds estimates by $118.92K, with 32.91% YoY growth.
  • EPS of -0.11 misses estimates by -0.07, with 45.00% YoY growth.
  • Next Earnings Release

    Fennec Pharmaceuticals Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    21 hours ago
    -6.37%
    Fennec Pharmaceuticals shares are trading lower fo... Unlock content with Pro Subscription
    5 months ago
    -11.19%
    Fennec Pharmaceuticals shares are trading lower after the company reported a year-over-year decrease in Q4 financial results.